Infratentorial posterior reversible encephalopathy syndrome in INFβ1a-treated multiple sclerosis patient
- PMID: 38386046
- DOI: 10.1007/s00415-024-12226-2
Infratentorial posterior reversible encephalopathy syndrome in INFβ1a-treated multiple sclerosis patient
Similar articles
-
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.Mult Scler. 2016 Oct;22(12):1626-1628. doi: 10.1177/1352458516641774. Epub 2016 Mar 24. Mult Scler. 2016. PMID: 27012659
-
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.Mult Scler Relat Disord. 2014 Nov;3(6):728-31. doi: 10.1016/j.msard.2014.08.004. Epub 2014 Sep 10. Mult Scler Relat Disord. 2014. PMID: 25891552
-
Delayed Toxic-Hypoxic Leukoencephalopathy After Posterior Reversible Encephalopathy Syndrome.R I Med J (2013). 2022 Nov 1;105(9):37-39. R I Med J (2013). 2022. PMID: 36300963 No abstract available.
-
[MRI alterations in immunomodulation].Nervenarzt. 2018 Aug;89(8):945-957. doi: 10.1007/s00115-018-0565-6. Nervenarzt. 2018. PMID: 30030575 Review. German.
-
Rituximab-associated posterior reversible encephalopathy syndrome.Int J Rheum Dis. 2019 Jan;22(1):160-165. doi: 10.1111/1756-185X.13427. Epub 2018 Nov 5. Int J Rheum Dis. 2019. PMID: 30398015 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources